As of April 2025 Rigel Pharmaceuticals has a market cap of NZ$0.52 Billion. This makes Rigel Pharmaceuticals the world's 7485th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$0.52 B | 1.58% |
2024 | NZ$0.51 B | 28.9% |
2023 | NZ$0.39 B | -2.09% |
2022 | NZ$0.40 B | -38.45% |
2021 | NZ$0.66 B | -19.06% |
2020 | NZ$0.81 B | 53.56% |
2019 | NZ$0.53 B | -6.88% |
2018 | NZ$0.57 B | -28.38% |
2017 | NZ$0.80 B | 135.43% |
2016 | NZ$0.33 B | -15.21% |
2015 | NZ$0.40 B | 57.17% |
2014 | NZ$0.25 B | -15.97% |
2013 | NZ$0.30 B | -55.91% |
2012 | NZ$0.68 B | -4.4% |
2011 | NZ$0.72 B | 41.17% |
2010 | NZ$0.51 B | -25% |
2009 | NZ$0.68 B | 34.89% |
2008 | NZ$0.50 B | -51.52% |
2007 | NZ$1.04 B | 145.18% |
2006 | NZ$0.42 B | 39.79% |
2005 | NZ$0.30 B | -54.89% |
2004 | NZ$0.67 B | 53.63% |
2003 | NZ$0.43 B | 355.53% |
2002 | NZ$96.14 M | -77.24% |
2001 | NZ$0.42 B | -49.12% |
2000 | NZ$0.83 B |
On Apr 6th, 2025 the market cap of Rigel Pharmaceuticals was reported to be: